ATM and endometrial cancer: Recently, in two progesterone responsive and progesterone-insensitive human endometrial cancer cell lines (162), ATM protein was shown by reverse-phase protein array (RPPA) to participate in progesterone stimulation to suppress carcinogenesis in the endometrium (162).